John B Rhodes Insider Trading $TNXP Tonix Pharmaceuticals Holding Corp.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John B Rhodes.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John B Rhodes. John B Rhodes is Director in Tonix Pharmaceuticals Holding Corp. ($TNXP).
John B Rhodes in Tonix Pharmaceuticals Holding Corp.
Trading Symbol: TNXPIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John B Rhodes: Director
Holdings: 23,470 shares
Current Value: $12,439
Latest Transaction: May 06 2020
$TNXP Market Capitalization: $21.31M
$TNXP Previous Close: $0.53
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of John B Rhodes in Tonix Pharmaceuticals Holding Corp.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 06 2020 | TNXP | Tonix Pharmaceutic ... | Rhodes John B | Director | Option Exercise | A | 0.77 | 75,000 | 57,750 | 75,000 | |
May 08 2019 | TNXP | Tonix Pharmaceutic ... | Rhodes John B | Director | Option Exercise | A | 2.05 | 45,000 | 92,250 | 45,000 | |
Jun 13 2018 | TNXP | Tonix Pharmaceutic ... | Rhodes John B | Director | Option Exercise | A | 4.25 | 30,000 | 127,500 | 30,000 | |
Jun 06 2018 | TNXP | Tonix Pharmaceutic ... | Rhodes John B | Director | Buy | P | 3.33 | 7,500 | 24,975 | 23,470 | 16 K to 23.5 K (+46.96 %) |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | Rhodes John B | Director | Option Exercise | M | 0.00 | 600 | 0 | 0 | |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | Rhodes John B | Director | Option Exercise | M | 0.00 | 1,125 | 0 | 0 | |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | Rhodes John B | Director | Option Exercise | M | 0.00 | 1,125 | 0 | 0 | |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | Rhodes John B | Director | Buy | M | 0.00 | 600 | 0 | 8,720 | 8.1 K to 8.7 K (+7.39 %) |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | Rhodes John B | Director | Buy | M | 0.00 | 1,125 | 0 | 14,845 | 13.7 K to 14.8 K (+8.20 %) |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | Rhodes John B | Director | Buy | M | 0.00 | 1,125 | 0 | 15,970 | 14.8 K to 16 K (+7.58 %) |
Jun 21 2017 | TNXP | Tonix Pharmaceutic ... | Rhodes John B | Director | Option Exercise | A | 4.18 | 30,000 | 125,400 | 30,000 | |
Oct 31 2016 | TNXP | Tonix Pharmaceutic ... | Rhodes John B | Director | Option Exercise | P | 0.63 | 25,000 | 15,750 | 25,000 | |
Oct 31 2016 | TNXP | Tonix Pharmaceutic ... | Rhodes John B | Director | Buy | P | 0.00 | 25,000 | 0 | 137,196 | 112.2 K to 137.2 K (+22.28 %) |
Jun 21 2016 | TNXP | Tonix Pharmaceutic ... | Rhodes John B | Director | Buy | P | 2.00 | 25,000 | 50,000 | 112,196 | 87.2 K to 112.2 K (+28.67 %) |
May 31 2016 | TNXP | Tonix Pharmaceutic ... | Rhodes John B | Director | Option Exercise | A | 0.00 | 11,250 | 0 | 11,250 | |
Feb 10 2016 | TNXP | Tonix Pharmaceutic ... | Rhodes John B | Director | Option Exercise | A | 0.00 | 11,250 | 0 | 0 | |
Jul 17 2015 | TNXP | Tonix Pharmaceutic ... | Rhodes John B | Director | Buy | P | 7.50 | 6,000 | 45,000 | 81,196 | 75.2 K to 81.2 K (+7.98 %) |
Feb 27 2015 | TNXP | Tonix Pharmaceutic ... | Rhodes John B | Director | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
Feb 27 2015 | TNXP | Tonix Pharmaceutic ... | Rhodes John B | Director | Option Exercise | A | 5.95 | 7,500 | 44,625 | 7,500 | |
Nov 03 2014 | TNXP | Tonix Pharmaceutic ... | Rhodes John B | Director | Option Exercise | A | 6.68 | 7,500 | 50,100 | 7,500 |
Page: 1